News

QR-010, a RNA-based oligonucleotide, is designed to address the underlying cause of the disease by repairing the mRNA defect encoded by the DF508 mutation in the CFTR gene

In the last three years, Pro Bono Bio has successfully launched and grown Flexiseq and Flexiseq Sport across the UK and other global markets including Europe, Asia and

With access to these funds, WCCT Global is pursuing both strategic organic expansion and new research capabilities within Asia and Europe, with the intent of improving their early

BARDA is a division of the U.S. Department of Health and Human Services that manages the advanced development and purchase of medical countermeasures for public health threats. Aeolus

The MAA is based on results from two global Phase III clinical trials that examined the efficacy, safety and pharmacokinetics of Alprolix for hemophilia B. The two trials

The proposed indication for Strensiq is for long-term enzyme replacement therapy in patients with pediatric-onset hypophosphatasia (HPP) to treat the bone manifestations of the disease. anuma is proposed

RVO is a significant cause of vision impairment and a chronic disease that requires early and ongoing management to obtain the best possible vision. The company said that

Humira is designed for the treatment of these adults with an inadequate response to conventional systemic HS therapy. HS, referred to as acne inversa, is a painful, chronic

The Eurostars project "BUPI – a long-acting lozenge with bupivacaine for pain relief of Oral Mucositis in cancer patients" will be managed by Moberg Pharma and includes six